<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37199068</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>03</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1447-0756</ISSN><JournalIssue CitedMedium="Internet"><Volume>49</Volume><Issue>8</Issue><PubDate><Year>2023</Year><Month>Aug</Month></PubDate></JournalIssue><Title>The journal of obstetrics and gynaecology research</Title><ISOAbbreviation>J Obstet Gynaecol Res</ISOAbbreviation></Journal><ArticleTitle>Pseudo-pseudo Meigs syndrome in systemic lupus erythematosus misdiagnosed as pseudo-Meigs' syndrome: A case report.</ArticleTitle><Pagination><StartPage>2199</StartPage><EndPage>2204</EndPage><MedlinePgn>2199-2204</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/jog.15677</ELocationID><Abstract><AbstractText>Symptoms of pelvic masses, elevated serum CA125 levels, massive ascites, and pleural effusion in female patients are usually associated with malignancy. Some benign ovarian tumors or other nonmalignant tumors may also produce similar symptoms, called Meigs syndrome or pseudo-Meigs' syndrome, which should be one of the differential diagnoses. However, there is an extremely rare form of SLE called pseudo-pseudo Meigs syndrome (PPMS), which may also present with the above symptoms, but is not associated with any of the tumors. In this paper, we report a case of a 47-year-old woman who presented with abdominal distention. The patient was found to have elevated serum CA125 levels to 182.9&#x2009;U/mL before the operation. Her PET-CT suggested a large heterogeneous mass in the pelvis measuring 8.2&#x2009;&#xd7;&#x2009;5.8&#x2009;cm with a large amount of ascites. She was initially diagnosed with ovarian cancer and underwent exploratory laparotomy. Pathology of the surgical specimen revealed a uterine leiomyoma. Two months after discharge, the patient's ascites reappeared along with recurrent intestinal obstruction. After ascites and serological tests, she was eventually diagnosed with systemic lupus erythematosus and received systemic hormonal therapy.</AbstractText><CopyrightInformation>&#xa9; 2023 Japan Society of Obstetrics and Gynecology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>He</LastName><ForeName>Jiaqi</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-3433-1604</Identifier><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang, Liaoning Province, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Jinke</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-8876-3541</Identifier><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang, Liaoning Province, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fan</LastName><ForeName>Bao</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang, Liaoning Province, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yan</LastName><ForeName>Liya</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang, Liaoning Province, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ouyang</LastName><ForeName>Ling</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang, Liaoning Province, People's Republic of China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>Australia</Country><MedlineTA>J Obstet Gynaecol Res</MedlineTA><NlmUniqueID>9612761</NlmUniqueID><ISSNLinking>1341-8076</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008539" MajorTopicYN="Y">Meigs Syndrome</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001201" MajorTopicYN="N">Ascites</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072078" MajorTopicYN="N">Positron Emission Tomography Computed Tomography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000008" MajorTopicYN="Y">Abdominal Neoplasms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003951" MajorTopicYN="N">Diagnostic Errors</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">case report</Keyword><Keyword MajorTopicYN="N">pseudo-Meigs' syndrome</Keyword><Keyword MajorTopicYN="N">pseudo-pseudo Meigs syndrome</Keyword><Keyword MajorTopicYN="N">systemic lupus erythematosus</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>8</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>3</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>18</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>18</Day><Hour>4</Hour><Minute>7</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37199068</ArticleId><ArticleId IdType="doi">10.1111/jog.15677</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Okuchi Y, Nagayama S, Mori Y, Kawamura J, Matsumoto S, Nishimura T, et al. VEGF hypersecretion as a plausible mechanism for pseudo-Meigs' syndrome in advanced colorectal cancer. Jpn J Clin Oncol. 2010;40(5):476-81.</Citation></Reference><Reference><Citation>Tansir G, Kumar P, Pius A, Sunny SK, Soneja M. Pseudo-pseudo Meigs' syndrome: a rare presentation of systemic lupus erythematosus. Reumatismo. 2019;71(2):108-12.</Citation></Reference><Reference><Citation>Tjalma WA. Ascites, pleural effusion, and CA 125 elevation in an SLE patient, either a Tjalma syndrome or, due to the migrated Filshie clips, a pseudo-Meigs syndrome. Gynecol Oncol. 2005;97(1):288-91.</Citation></Reference><Reference><Citation>Man BL, Mok CC. Serositis related to systemic lupus erythematosus: prevalence and outcome. Lupus. 2005;14(10):822-6.</Citation></Reference><Reference><Citation>Weinstein PJ, Noyer CM. Rapid onset of massive ascites as the initial presentation of systemic lupus erythematosus. Am J Gastroenterol. 2000;95(1):302-3.</Citation></Reference><Reference><Citation>Pott J&#xfa;nior H, Amate Neto A, Teixeira MA, Provenza JR. Ascites due to lupus peritonitis: a rare form of onset of systemic lupus erythematosus. Rev Bras Reumatol. 2012;52(1):116-9.</Citation></Reference><Reference><Citation>Takeno M, Ishigatsubo Y. Intestinal manifestations in systemic lupus erythematosus. Intern Med. 2006;45(2):41-2.</Citation></Reference><Reference><Citation>Ghavidel A. Clinical dilemma of acute abdomen in patients with systemic lupuserythematosus: a case report. J Anal Res Clin Med. 2017;5(2):69-74.</Citation></Reference><Reference><Citation>Patsner B. Meigs syndrome and &#x201c;false positive&#x201d; preoperative serum CA-125 levels: analysis of ten cases. Eur J Gynaecol Oncol. 2000;21(4):362-3.</Citation></Reference><Reference><Citation>Zeimet AG, Offner FA, Marth C, Heim K, Feichtinger H, Daxenbichler G, et al. Modulation of CA-125 release by inflammatory cytokines in human peritoneal mesothelial and ovarian cancer cells. Anticancer Res. 1997;17(4B):3129-31.</Citation></Reference><Reference><Citation>Lee SY, Lee SW, Chung WT. Severe inflammation may be caused by hyperferritinemia of pseudo-pseudo Meigs' syndrome in lupus patients: two cases reports and a literature review. Clin Rheumatol. 2013;32(12):1823-6.</Citation></Reference><Reference><Citation>Dalvi SR, Yildirim R, Santoriello D, Belmont HM. Pseudo-pseudo Meigs' syndrome in a patient with systemic lupus erythematosus. Lupus. 2012;21(13):1463-6.</Citation></Reference><Reference><Citation>Yang Z, Liang Y, Li C, Zhong R. Serum CA125 elevation is independently associated with serositis in SLE patients. Clin Exp Rheumatol. 2012;30(1):93-8.</Citation></Reference><Reference><Citation>Szekanecz E, Szucs G, Szekanecz Z, Tarr T, Antal-Szalm&#xe1;s P, Szamosi S, et al. Tumor-associated antigens in systemic sclerosis and systemic lupus erythematosus: associations with organ manifestations, immunolaboratory markers and disease activity indices. J Autoimmun. 2008;31(4):372-6.</Citation></Reference><Reference><Citation>Miret C, Font J, Molina R, Filella X, Vivancos J, Mu&#xf1;oz-Rodriguez FJ, et al. Lack of correlation between tumor markers (CA 125 and SCC) and systemic lupus erythematosus activity. Anticancer Res. 1998;18(2B):1341-4.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>